Keywords: SPMs; second primary malignancies; EBR; external beam radiation; OAC; ophthalmic artery chemosurgery; ERG; electroretinogram; PFS; progression-free survival (an event included any treatment with enucleation, external beam radiation and OAC following compl
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ADC; arginine decarboxylase; ODC; ornithine decarboxylase; PA; polyamines; Put; putrescine; Spd; spermidine; Spm; spermine; T-Spm; thermospermine; SPDS; Spd synthase; SPMS; Spm synthase; ACL5; Acaulis5; Polyamine synthesis; Tomato; Solanum lycopersicum; F
Keywords: CNAs; copy number aberrations; CRT; chemoradiotherapy; FA; Fanconi anemia; HPV; human papillomavirus; HR; homologous recombination; HRD; Homologous Recombination Deficiency; L/P-SCC; laryngeal and pharyngeal squamous cell carcinoma; LST; Large Scale Trans
Keywords: AA; Arachidonic acid; ALX/FPR2; Lipoxin A4/formyl peptide receptor 2; AnxA1; Annexin A1; ASA; Acetylsalicylic acid; AT; Aspirin-triggered; BHR; Bronchial hyper-reactivity; COX; Cyclooxygenase; DHA; Docosahexaenoic acid; Eos; Eosinophils; EPA; Eicosapentae
Keywords: ALS; amyotrophic lateral sclerosis; BDNF; brain-derived neurotropic factor; CerS; ceramide synthase; CNS; central nervous system; CPL; cecal ligation and puncture; cPLA2; cytosolic phospholipase A2; CSA; cyclosporine A; CTL; cytotoxic T lymphocytes; CYP45
Keywords: Ginger; Multiple sclerosis; Experimental autoimmune encephalomyelitis; Therapeutic potentials; AP-1; Activator protein 1; APCs; Antigen-presenting cells; ASC; apoptosis speck-like protein containing CARD; BAFF; B cell-activating factor belonging to the TN
Keywords: Arginase; Nitrated proteins; NOS-like activity; Putrescine; Seed dormancy; Ubiquitin; 3-NT; 3-nitro-tyrosine; Arg; arginine; cPTIO; 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide; Orn; ornithine; NO2â; nitrite; NO; nitric oxide; NOS-l
Keywords: IL-32; Multiple sclerosis; Polymorphism; RRMS; SPMS;
Keywords: NMOSD; Neuromyelitis optica spectrum disorder; MS; Multiple sclerosis; RRMS; Relapsing-remitting multiple sclerosis; SPMS; Secondarily progressive multiple sclerosis; PPMS; Primary progressive multiple sclerosis; EP; Evoked potential; AQP4-Ab; Anti-aquapo
Keywords: AA; arachidonic acid; ABCA1; adenosine triphosphate-binding cassette transporter A1; ACE-I; angiotensin-converting enzyme inhibitor; ACSL1; acyl-CoA synthase 1; ADMA; asymmetric dimethylarginine; Akt; protein kinase B; Aldo; aldosterone; AMPK; adenosine m
Keywords: AAN; American Academy of Neurology; ABN; Association of British Neurologists; AUD; Australian dollars; CIS; clinically isolated syndrome; CNS; central nervous system; DMT; disease-modifying therapy; EDSS; Kurtzke Expanded Disability Status Scale; EMA; Eur
Keywords: CNS; central nervous system; EAE; experimental autoimmune encephalomyelitis; MS; multiple sclerosis; PPMS; primary-progressive multiple sclerosis; RRMS; relapsing remitting multiple sclerosis; SPMS; secondary progressive multiple sclerosis; Cytokines; IL-
Keywords: RRMS; relapsing-remitting multiple sclerosis; SPMS; secondary progressive multiple sclerosis; EDDS; expanded disability status scale; UCCA; upper cervical cord area; GM; brain grey matter; WM; brain white matter; TBV; total brain volume; VBM; voxel base
Keywords: ADEM; acute demyelinating encephalomyelitis; AION; anterior ischaemic optic neuropathy; AQP4; aquaporin-4; AZOOR; acute zonal occult outer retinopathy; CF; count fingers; CRION; chronic relapsing inflammatory optic neuropathy; CSF; cerebrospinal fluid; CT
Keywords: BBB; blood-brain barrier; CNS; central nervous system; DMF; dimethyl fumarate; DMT; disease-modifying therapy; EDSS; Expanded Disability Status Scale; FDA; Food and Drug Administration; GA; glatiramer acetate; JCV; John Cunningham virus; MRI; magnetic res
The Bayesian risk estimate at onset (BREMSO) correlates with cognitive and physical disability in patients with early multiple sclerosis
Keywords: Multiple sclerosis; Bayesian Risk Estimate for MS at Onset (BREMSO); Predictive score; Multiple sclerosis severity score (MSSS); Symbol digit modalities test (SDMT); Magnetic resonance imaging (MRI); BREMSO; Bayesian risk estimate for MS at onset; CC; Cor
Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting
Keywords: Disability worsening; Natalizumab; Relapsing-remitting multiple sclerosis; EDSS milestones; CP; cumulative probability; DMT; disease-modifying therapy; EDSS; Expanded Disability Status Scale; RRMS; relapsing-remitting multiple sclerosis; SPMS; secondary p
Phytohormone participation during Citrus sinensis non-host response to Xanthomonas campestris pv. vesicatoria
Keywords: Biotic stress; Incompatible interaction; Plant - pathogen interaction; Sweet orange; Transcriptomic analysis; Xanthomonas citri subsp. citri; ABA; Abscisic Acid; ABA1/ZEP; Zeaxanthin epoxidase; ABF3/DPBF5; Abscisic acid responsive elements-binding factor
Genome-wide identification of genes involved in polyamine biosynthesis and the role of exogenous polyamines in Malus hupehensis Rehd. under alkaline stress
Keywords: ADC; arginine decarboxylase; BR; brassinosteroid; JA; jasmonic acid; ODC; ornithine decarboxylase; PA; polyamine(s); Put; putrescine; qPCR; quantitative polymerase chain reaction; SAMDC; S-adenosylmethionine decarboxylase; SL; strigolactone; Spd; spermidi
Evidence of axonal damage in cerebellar peduncles without T2-lesions in multiple sclerosis
Keywords: 9-HPT; 9-Hole peg test; AD; Axial diffusivity; CP; Cerebellar peduncle; CSF; Cerebro-spinal fluid; DD; Disease duration; DTI; Diffusion tensor imaging; EDSS; Expanded Disability Status Scale; FA; Fractional anisotropy; FSL; Functional magnetic resonance i
Autoimmunity in multiple sclerosis: role of sphingolipids, invariant NKT cells and other immune elements in control of inflammation and neurodegeneration
Keywords: Ag; antigen; APC; antigen presenting cell; BBB; blood brain barrier; BCR; B cell receptor; BDNF; brain-derived neurotrophic factor; CIS; clinically isolated syndrome; CLR; C-type lectin receptor; CNS; central nervous system; CSF; cerebrospinal fluid; DAMP
Thioredoxin-1, redox factor-1 and thioredoxin-interacting protein, mRNAs are differentially expressed in Multiple Sclerosis patients exposed and non-exposed to interferon and immunosuppressive treatments
Keywords: Trx1; Thioredoxin 1; Trx1R; Thioredoxin 1 reductase; Trx2; Thioredoxin 2; Trx2R; Thioredoxin 2 reductase; Txnip; Thioredoxin-interacting protein; Ref-1; Redox factor-1; MS; Multiple Sclerosis; RRMS; Relapsing-Remitting Multiple Sclerosis; SPMS; Secondary
Multiple sclerosis in Belgian children: AÂ multicentre retrospective study
Keywords: Multiple sclerosis; Paediatric multiple sclerosis; Childhood; Adolescence; ADEM; acute disseminated encephalomyelitis; ADEMON; acute disseminated encephalomyelitis followed by optic neuritis; AQP4; aquaporine 4; CMV; cytomegalovirus; DIS; dissemination in
Predicting the Effect of Amino Acid Single-Point Mutations on Protein Stability-Large-Scale Validation of MD-Based Relative Free Energy Calculations
Keywords: SPMs; single amino acid point mutations; MD; molecular dynamics; FEP; free energy perturbation; MUE; mean unsigned error; RMSE; root mean squared error; protein stability; protein engineering; molecular dynamics; protein folding;
Metabolomics: A potential way to know the role of vitamin D on multiple sclerosis
Keywords: CIS; clinically isolated syndrome; CLIA; chemiluminescence immunoassays; CNS; central nervous system; CPB; competitive protein binding assay; DEQAS; vitamin D external quality assessment scheme; EAE; experimental autoimmune encephalomyelitis; EBNA1; EBV n
Extracellular miR-145, miR-223 and miR-326 expression signature allow for differential diagnosis of immune-mediated neuroinflammatory diseases
Keywords: MicroRNAs; Multiple sclerosis; Neuromyelitis optica spectrum disorder; Neuropsychiatric systemic lupus erythematosus; Immune-mediated neuroinflammatory diseases; AQP4; aquaporin-4; CD47; cluster of differentiation 47; cDNA; complementary DNA; EDSS; expand
Lipidomics in translational research and the clinical significance of lipid-based biomarkers
Keywords: 5-HETE; 5-hydroxyicosatetraenoic acid; 12-HETE; 12-hydroxyicosatetraenoic acid; 15-HETE; 15-hydroxyicosatetraenoic acid; aa; diacyl; ae; acyl-alkyl; ACs; acylcarnitines; ACOG; The American College of Obstetricians and Gynecologists; AD; Alzheimer's dise
A low vitamin D status at diagnosis is associated with an early conversion to secondary progressive multiple sclerosis
Keywords: MS; multiple sclerosis; RRMS; relapsing remitting multiple sclerosis; SPMS; secondary progressive multiple sclerosis; DMD; disease modulating drugs; CIS; clinically isolated syndrome; EDSS; expanded disability status scale; 25-Hydroxyvitamin D; Disability
Resolvin D1 protects the liver from ischemia/reperfusion injury by enhancing M2 macrophage polarization and efferocytosis
Keywords: Arginase 1; Arg1; cyclooxygenase; COX; ALX/N-formyl peptide receptor 2; ALX/FPR2; hepatocytes; HPCs; interleukin 1; IL-1; ischemia/reperfusion; IR; Kupffer cell; KC; lipopolysaccharide; LPS; liposome clodronate; LC; lipoxins; Lxs; lipoxygenase; LOX; nucle
Reporting quality of randomized-controlled trials in multiple sclerosis from 2000 to 2015, based on CONSORT statement
Keywords: RCT; randomized controlled trial; CONSORT; Consolidated Standards of Reporting Trials; MS; multiple sclerosis; RRMS; Relapsing Remitting MS; SPMS; Secondary Progressive MS; PPMS; Primary Progressive MS; CIS; Clinically Isolated Syndrome; Multiple sclerosi
Targeting demyelination and virtual hypoxia with high-dose biotin as a treatment for progressive multiple sclerosis
Keywords: Multiple sclerosis; Biotin; Promyelinogenic agent; Virtual hypoxia; ACC; acetyl-CoA carboxylase; AMN; adrenomyeloneuropathy; BBB; blood-brain barrier; BTBGD; biotin-thiamine responsive basal ganglia disease; EDSS; Expanded Disability Status Scale; HLCS;
Novel composite MRI scale correlates highly with disability in multiple sclerosis patients
Keywords: COMRIS-CDO-SDMT; combinatorial MRI scale-cognitive disability optimized by SDMT; COMRIS-CTD-v1; combinatorial MRI scale of CNS tissue destruction version 1; COMRIS-PDO-EDSS; combinatorial MRI scale-physical disability optimized by EDSS; COMRIS-PDO-SNRS; c
ReviewMultiple sclerosis: Lessons from molecular neuropathology
Keywords: MS; multiple sclerosis; RRMS; relapsing remitting multiple sclerosis; SPMS; secondary progressive multiple sclerosis; PPMS; primary progressive multiple sclerosis; MOG; myelin oligodendrocyte glycoprotein; Multiple sclerosis; Demyelination; Neurodegenerat
Daclizumab (anti-CD25) in multiple sclerosis
Keywords: CEL; Contrast enhancing lesion; CSF; Cerebrospinal fluid; DAC; Daclizumab; EDSS; Expanded Disability Status Scale; MSFC; Multiple Sclerosis Functional Composite; MSIS; Multiple Sclerosis Impact Scale; NRS; Neurological Rating Scale; RRMS; Relapsing-remitt
Regular ArticleProgressive multiple sclerosis cerebrospinal fluid induces inflammatory demyelination, axonal loss, and astrogliosis in mice
Keywords: CSF; cerebrospinal fluid; CTRL; control; EDSS; expanded disability status scale; ITMTX; intrathecal methotrexate; MS; multiple sclerosis; PPMS; primary progressive multiple sclerosis; SPMS; secondary multiple sclerosis progressive; RRMS; relapsing/remitti
6.7-kbp deletion in LILRA3 (ILT6) gene is associated with later onset of the multiple sclerosis in a Polish population
Keywords: EDSS; expanded disability status scale; HLA; human leukocyte antigen; LD; linkage disequilibrium; LILRA3; leukocyte immunoglobulin - like subfamily A, member 3; MS; multiple sclerosis; MSSS; multiple sclerosis severity scale; PCR; polymerase chain react
Short communicationType 1 immune response in progressive multiple sclerosis
Keywords: Multiple sclerosis; T-bet; Transcription factor; PPMS; SPMS;
Clinical Improvement after Extracranial Venoplasty in Multiple Sclerosis
Keywords: CCSVI; chronic cerebrospinal venous insufficiency; MS; multiple sclerosis; MSIS-29; Multiple Sclerosis Impact Scale 29; PPMS; primary progressive multiple sclerosis; RRMS; relapsing-remitting multiple sclerosis; SD; standard deviation; SPMS; secondary pro
New insights into the role of spermine in Arabidopsis thaliana under long-term salt stress
Keywords: ABA; abscisic acid; ACL5; acaulis 5; ADC; arginine decarboxylase; DW; dry weight; FW; fresh weight; HPLC; high-pressure liquid chromatography; NBT; nitro-blue-tetrazolium; PS II; photosystem II; SAMDC; S-adenosylmethionine decarboxylase; SEM; standard err
Clinical use of H1 MR spectroscopy in assessment of relapsing remitting and secondary progressive multiple sclerosis
Keywords: Multiple sclerosis; RRMS; SPMS; EDSS; Brain metabolites; H1 MR spectroscopy
Fornix damage limits verbal memory functional compensation in multiple sclerosis
Keywords: RRMS; relapsing-remitting multiple sclerosis; SPMS; secondary-progressive multiple sclerosis; MTL; mesial temporal lobe; fMRI; functional magnetic resonance imaging; DTI; diffusion tensor imaging; FA; fractional anisotropy; TBSS; tract-based spatial stati
Urinary Diversion/Reconstruction for Cases of Catheter Intolerant Secondary Progressive Multiple Sclerosis With Refractory Urinary Symptoms
Keywords: urinary bladder, neurogenic; multiple sclerosis, chronic progressive; urinary diversion; urinary incontinence; urinary tract infections; BMI; body mass index; EDSS; Expanded Disability Status Scale; HG; high grade surgical complications; MS; multiple scle
Radial diffusivity predicts demyelination in ex vivo multiple sclerosis spinal cords
Keywords: MS; multiple sclerosis; CNS; central nervous system; PPMS; primary progressive multiple sclerosis; SPMS; secondary progressive multiple sclerosis; MRI; magnetic resonance imaging; T2W; T2 weighted; DTI; diffusion tensor imaging; ADC; apparent diffusion co
Penalized functional regression analysis of white-matter tract profiles in multiple sclerosis
Keywords: MS; multiple sclerosis; CIS; clinically isolated syndrome; RRMS; relapsing-remitting multiple sclerosis; SPMS; secondary-progressive multiple sclerosis; PPMS; primary-progressive multiple sclerosis; DTI; diffusion tensor imaging; FA; fractional anisotro
MRM assay for quantitation of complement components in human blood plasma - a feasibility study on multiple sclerosis
Keywords: RRMS; relapsing-remitting multiple sclerosis; SPMS; secondary progressive multiple sclerosis; C3; Complement C3; C4; Complement C4; C5; Complement C5; C9; Complement C9; fB; Complement factor B; fH; Complement factor H; CRP; C-reactive protein.; Selected
Reduced cortisol levels in cerebrospinal fluid and differential distribution of 11β-hydroxysteroid dehydrogenases in multiple sclerosis: Implications for lesion pathogenesis
Keywords: 11bHSD1/2; 11β-hydroxysteroid dehydrogenase type 1/2; CNS; central nervous system; CSF; cerebrospinal fluid; DHEA; dehydroepiandrosterone; EAE; experimental autoimmune encephalomyelitis; HPA; hypothalamo-pituitary-adrenal; MRI; magnetic resonance ima
The drought response of Theobroma cacao (cacao) and the regulation of genes involved in polyamine biosynthesis by drought and other stresses
Keywords: Polyamine; Theobroma cacao; Drought; Nep1; Wounding; Phytophthora; ODC; ADC; SAMDC; SPDS; SPMS
The incomplete nature of multiple sclerosis relapse resolution
Keywords: Multiple sclerosis; Clinical course; RRMS; SPMS; PPMS; PRMS; Natural history; MRI; Disability; Relapse; Worsening
The polyamine spermine protects against high salt stress in Arabidopsis thaliana
Keywords: ADC; Arg decarboxylase; Arg; arginine; CAX; calcium exchanger; CDPK; calcium dependent protein kinase; CLC; chloride channel; GluR; glutamate receptor; MPK; mitogen-activated protein kinase; PA; polyamine; PAO; polyamine oxidase; PCR; polymerase chain rea
Cognitive impairment and decline in different MS subtypes
Keywords: Multiple sclerosis; SPMS; PPMS; RRMS; Cognition; working memory; Information processing speed